Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

Renin–angiotensin–aldosterone system inhibitors (RAASi) are known to improve outcomes in patients who have heart failure with reduced ejection fraction (HFrEF). To reduce mortality in these patients, RAASi should be uptitrated to the maximally tolerated dose. However, RAASi may also cause hyperkalem...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Card Fail Rev
Hauptverfasser: Rosano, Giuseppe MC, Spoletini, Ilaria, Vitale, Cristiana, Agewall, Stefan
Format: Artigo
Sprache:Inglês
Veröffentlicht: Radcliffe Cardiology 2019
Schlagworte:
Clinical Practice
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6848927/
https://ncbi.nlm.nih.gov/pubmed/31768268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/cfr.2019.8.2
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge